Leading health insurers such as UnitedHealthcare, WellPoint, and Humana have retained CRA to assess the competitive effects of mergers and present our findings to federal and state regulators. Our experts have analyzed the product and geographic markets for commercial and government-sponsored health plans, the likelihood that buy-side market power could be exercised, the competitive constraints of entry and expansion, and the effect of regulations and oversight on plan pricing and quality.
Insights from the final panel at the CRA Brussels Conference 2025: Shaping the future of digital regulation and competition
The closing panel from 2025 CRA Brussels Conference, “Digital Regulation in Action: The DMA, AI, and the Future of Competition” moderated by Dr Matteo Foschi